FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: The Food and Drug Administration's decisions on vaccine safety and approval directly impact public health policies and immunization programs administered by the State of Hawaiʻi Department of Health across the islands.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.